Shanghai RAAS Blood Products Co., Ltd.

Shenzhen Stock Exchange 002252.SZ

Shanghai RAAS Blood Products Co., Ltd. Revenue for the year ending December 31, 2023: USD 1.12 B

Shanghai RAAS Blood Products Co., Ltd. Revenue is USD 1.12 B for the year ending December 31, 2023, a 17.87% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Shanghai RAAS Blood Products Co., Ltd. Revenue for the year ending December 31, 2022 was USD 951.65 M, a 41.03% change year over year.
  • Shanghai RAAS Blood Products Co., Ltd. Revenue for the year ending December 31, 2021 was USD 674.80 M, a 59.49% change year over year.
  • Shanghai RAAS Blood Products Co., Ltd. Revenue for the year ending December 31, 2020 was USD 423.09 M, a 13.98% change year over year.
  • Shanghai RAAS Blood Products Co., Ltd. Revenue for the year ending December 31, 2019 was USD 371.20 M, a 41.50% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
Shenzhen Stock Exchange: 002252.SZ

Shanghai RAAS Blood Products Co., Ltd.

CEO Mr. Jun Xu
IPO Date June 12, 2008
Location China
Headquarters No. 2009, Wangyuan Road
Employees 3,254
Sector Health Care
Industries
Description

Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. It also provides testing services for blood products, vaccines, diagnostic reagents, and testing equipment. The company also exports its products to Southeast Asia and Latin America. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China.

Similar companies

000538.SZ

Yunnan Baiyao Group Co.,Ltd

USD 7.83

2.23%

000963.SZ

Huadong Medicine Co., Ltd

USD 4.53

2.64%

002304.SZ

Jiangsu Yanghe Brewery Joint-Stock Co., Ltd.

USD 10.96

2.23%

002236.SZ

Zhejiang Dahua Technology Co., Ltd.

USD 2.06

3.72%

002007.SZ

Hualan Biological Engineering Inc.

USD 2.17

2.25%

StockViz Staff

January 15, 2025

Any question? Send us an email